Copyright
©The Author(s) 2024.
World J Psychiatry. Jan 19, 2024; 14(1): 88-101
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88
Figure 2 Leave-one-out sensitivity plots of 5 metabolites on autism spectrum disorder.
A: Mendelian randomization (MR) leave-one-out sensitivity analysis for M34420: Des-Arg(9) bradykinin on autism spectrum disorder (ASD); B: MR leave-one-out sensitivity analysis for M36131: alpha-glutamyltyrosine on ASD; C: MR leave-one-out sensitivity analysis for M33138: oxidized bilirubin on ASD; D: MR leave-one-out sensitivity analysis for M32497: 10-undecenoate (11:1n1) on ASD; E: MR leave-one-out sensitivity analysis for M02137: biliverdin on ASD. MR: Mendelian randomization.
- Citation: Huang ZY, Lyu ZP, Li HG, You HZ, Yang XN, Cha CH. Des-Arg(9) bradykinin as a causal metabolite for autism spectrum disorder. World J Psychiatry 2024; 14(1): 88-101
- URL: https://www.wjgnet.com/2220-3206/full/v14/i1/88.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i1.88